QC
TARO

Quadrature Capital’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Quadrature Capital’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-2,196
Closed -$247K – 696
2017
Q2 		$247K Sell
2,196
-900
-29% -$102K 0.02% 468
2017
Q1 		$361K Sell
3,096
-5,865
-65% -$649K 0.03% 479
2016
Q4 		$942K Sell
8,961
-1,730
-16% -$181K 0.06% 295
2016
Q3 		$1.18M Buy
+10,691
New +$1.42M 0.1% 203

Other funds holding TARO

MICM
Matthews International Capital Management San Francisco, California $292M AUM 75.01% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

Quadrature Capital's TARO Position: Q3 2017 in Review

Quadrature Capital sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q3 2017, closing a stake of 2,196 shares — an estimated $247K sold.

Quadrature Capital first reported a position in TARO in Q3 2016 and held it in 4 quarters. The position peaked at $1.18M in Q3 2016. 133 funds tracked by Wall St. Rank hold TARO as of Q3 2017.

  • Quadrature Capital reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q3 2017 after selling out during the quarter.
  • Quadrature Capital sold 2,196 Taro Pharmaceutical Industries Ltd. shares in Q3 2017, an estimated $247K.
  • Quadrature Capital first reported a position in Taro Pharmaceutical Industries Ltd. in Q3 2016 and held it in 4 quarters.
  • Quadrature Capital's Taro Pharmaceutical Industries Ltd. position peaked at $1.18M in Q3 2016.
  • 133 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q3 2017.

Based on Quadrature Capital's 13F filing for Q3 2017, filed 13 Nov 2017.